The Na, K-ATPase consists of a-and b-subunits and actively transports Na out and K into the myocyte. It is the receptor for cardiac glycosides exerting its positive inotropic effect by inhibiting enzyme activity, decreasing the driving force for the Na / Ca-exchange and increasing cellular content and release of Ca during depolarization. The specific binding capacity for cardiac glycosides is utilized as a tool for Na, K-ATPase quantification with high accuracy and precision. In treatment of patients with heart failure cardiac glycosides improve symptoms and reduce the need for hospitalization without affecting mortality. In endomyocardial biopsies from patients with compromised cardiac function total Na, K-ATPase concentration is decreased by |40% and a correlation between decrease in heart function and decrease in Na, K-ATPase concentration exists. At the subunit level, the a1-, a3-and b1-proteins are reduced in human heart failure. During digitalization |30% of remaining Na, K-pumps are occupied by digoxin. Thus, a total of not less than half the Na, K-pumps may be out of function in the myocardium of digitalised heart failure patients. It is still a matter of debate whether a digitalis-like factor exists. There is a pressing need for the identification of its precise chemical structure, properties and quantitative relation to the Na, K-ATPase. It is recommended that cardiac glycosides are prescribed to heart failure patients who are still having heart failure symptoms after institution of mortality reducing therapy. Cardiac glycoside treatment is still the only safe inotropic drug for oral use that improves hemodynamics in patients with compromised cardiac function.
. Mechanism for the hemodynamic effects of digitalis
glycosides are effective in heart failure, the underlying glycosides mechanisms are still debated. Two mechanisms are of major importance for their hemodynamic effects, that is In 1997 Jens Christian Skou was awarded the Nobel their positive inotropic ( Fig. 1 ) and their neurohumoral Prize in chemistry for his discovery of the Na, K-adenosine effect. triphosphatase (Na, K-ATPase or Na, K-pump) in
The inotropic effect is generally accepted to be due to peripheral nerves of the shore crab [1, 2] . This membranehigh affinity binding of cardiac glycosides to the Na, bound Na, K-pump mediates the active transport of Na out K-ATPase. This leads to inhibition of the enzyme [4] and and K into the cell and has been identified in virtually all an increase in intracellular Na [5] . Hence, the Na / Caanimal tissues including the human myocardium. The exchanger activity is affected so that less Ca is extruded active Na and K transport is specifically inhibited by from the cell. Consequently, more Ca is accumulated in the cardiac glycosides [3] . While there is no doubt that cardiac sarcoplasmic reticulum and is available during subsequent contractions leading to increased force of contraction [6] . Increased contractility can also be observed when intracellular Na is raised by other pharmacologic interven- (A) Cardiac glycosides bind with high affinity to the Na, K-ATPase (NKA) and inhibit enzyme activity. Thereby, intracellular Na is increased and the driving force for the Na,Ca-exchanger (NCX) to extrude Ca from the cell is reduced. The remaining Ca is accumulated in the sarcoplasmic reticulum (SR) via the SR Ca-ATPase (SERCA) and is released during subsequent depolarizations leading to enhanced contractility. (B) The Ca-release from the SR has been found to be enhanced secondary to the interaction of cardiac glycosides with the Ca-release channel (ryanodine receptor, RyR). (C) Cardiac glycosides lead to a 'slip-mode' conduction of sodium channels (SOC) allowing Ca-ions to enter the cell via the channels. The interaction of cardiac glycosides with SOCs may be either direct or indirect (via NKA). See text for details and references.
tions such as opening Na-channels [7] showing effects like cardiac glycosides may induce a slip-mode conductance cardiac glycosides in human myocardium [8] . Proof for the through Na-channels [19] . In this model Na-channels allow role of the Na / Ca-exchanger in the action of cardiac Ca-ions to pass, thereby increasing Ca-influx and contracglycosides came very recently from experiments using tility. However, recently this slip-mode phenomenon has Na / Ca-exchanger knockout mice [9] . Studies that found been challenged [20] . Other investigators found that carno increase in overall Na-concentration in the cell upon diac glycosides enhance the Ca-release from the sarcoplasstimulation with ouabain indicate that it may be a compartmic reticulum (SR) by increasing single channel activity of mental increase in Na-concentration that is responsible for ryanodine-receptors [21, 22] . Thus, in addition to increaspositive inotropy [10] . This mechanism has earlier been ing SR load by Na, K-pump inhibition, amplification of SR described in smooth muscle, where Na, K-ATPase, Na / Ca-release may play a role. However, no evidence was Ca-exchanger and Ca-storage sites of the sarcoplasmic observed for enhancement of Ca-release from saponin reticulum have been found in close proximity to each other skinned fibre preparations from human heart when exposed [11, 12] , forming a functional unit that was named 'plasto ouabain (Schwinger and Muller-Ehmsen, unpublished merosome' [13] . In contrast to the widely accepted obobservation). servation of Na, K-ATPase inhibition by cardiac glycoBesides their direct positive inotropic effect, cardiac sides, Gao et al. recently described that Na, K-ATPase glycosides improve hemodynamics also by inhibition of activity may be enhanced by low concentrations of ouabain extra-cardiac Na, K-ATPase. Hence, cardiac glycosides and dihydro-ouabain within the first minutes of exposure may restore baroreceptor activity in congestive heart [14] . However, this observation demands further elucidafailure [23] . In addition, ouabain treatment is known to tion since the vast majority of investigations strongly favor stimulate vagal nerve activity decreasing heart rate [24] . an inhibition of Na, K-ATPase by cardiac glycosides This may be hemodynamically of special importance in [15, 16] causing a potassium loss from the human heart patients with heart failure where contractility decreases at [17] and significantly increased exercise induced potassium high heart rates due to the negative force-frequency-relarise during digitalization [18] .
tionship [25] . The increased vagal activity may also be A few years ago Santana et al. found evidence that generally beneficial mimicking b-adrenoceptor antagonist treatment. Although this effect of digitalis glycosides may assessment of Na, K-ATPase current in intact human to some extent seem outdated in the era of the b-adrenocardiomyocytes from failing hearts, we have to rely on ceptor antagonist for treatment of heart failure, it is of indirect evidence from the parameters were measured. In importance for patients not tolerating b-blockade. Thus, experimental heart failure and in human heart failure other effects than direct increase in contractility may play increased intracellular Na-concentrations were observed an important role for the benefits of cardiac glycosides in [41, 42] . The concentrations at 0.25 Hz in man were the treatment of patients with symptomatic heart failure.
estimated to be 8-16 mM in non-failing ventricular myocytes and 12-22 mM in failing cells (|50% increase) [42] . The reduced Na, K-ATPase activity is certainly a 2 . Quantitative and kinetic aspects of myocardial Na, major contributor to this finding in man, but other trans-K-ATPase porters like Na,H-exchanger [43] , the sodium-bicarbonate co-transporter or Na-channels may play a role [42, 44] . In Some decades ago cardiac glycoside binding was derabbit, similar increases in Na were measured, but the Na, veloped as a tool for Na, K-ATPase quantification [26] .
K-ATPase density was not reduced. Instead, an increased This method allows quantification of muscular Na, Ksodium influx was found to be responsible for increased ATPase with high accuracy and precision [27] . The Na, Na. Whatever the reason, higher Na-concentration means K-ATPase was found to be expressed in the human more substrate for Na, K-ATPase and higher enzyme myocardium several years ago [28] , and has been quanactivity. The Na affinities that have been observed for tified in both normal and diseased myocardium. In normal heterologously expressed human Na, K-ATPase isoforms human left ventricular myocardium a Na, K-ATPase vary considerably with K 8-25 mM in one study [45] 1 / 2 concentration of |700 pmol / g wet weight was found [29] . and K 1.5-2.8 mM in another study [46] . If the former
Hitherto, it has not been possible to quantify the absolute results are representative for human cardiomyocytes, the amounts of the various isoforms of the myocardial Na, activity of Na, K-ATPase enzymes will be considerably K-ATPase. In human dilated cardiomyopathy endomyocarincreased by the increase in intracellular Na, compensating dial biopsies showed a significant decrease of |40% in at least in part for reduced pump abundance. In fact, in the total Na, K-ATPase concentration [30] . Later, using data above mentioned rabbit model of heart failure where no from all available studies [30] [31] [32] [33] , it was concluded that decrease in overall Na, K-ATPase capacity was observed, there is a consistent and significant decrease of 26-32% in the sodium pump activity was even enhanced during heart Na, K-ATPase protein in the failing human heart [34] .
failure due to increased intracellular Na concentrations Concomittantly, the Na, K-ATPase activity is decreased in [41] . However, if the lower K reflects the actual 1 / 2 homogenates and membranes from failing human hearts situation in human cardiomyocytes, Na-dependent Na, K-
ATPase activation is already saturated at Na-concentraInterestingly, a close correlation was observed between tions of |10 mM. A further increase in intracellular Nadecreased left ventricular ejection fraction and decreased concentration will only insignificantly enhance overall Na, Na, K-ATPase concentration [30, 36] . A very interesting K-ATPase activity. In this case, a reduction in Na, Kand important question is, whether the reduction of Na, ATPase protein will directly translate to reduced enzyme K-ATPase is part of the reason for cardiac dysfunction activity, thus mimicking cardiac glycoside treatment. In and / or hypertrophy, whether it serves compensatory pureffect, contractility may be enhanced as compensation for poses with effects comparable to digitalis treatment, or the underlying disease. whether it just coincides with the disease progress. Data from hypertrophied dog heart indicate that reduced Na, K-ATPase expression occurs early in the development of 3 . Na, K-ATPase isoforms heart failure [37] . Contradictory model-dependent results were found in hypertrophied rat hearts with either unThe Na, K-ATPase is a heteromeric protein consisting changed [38] or reduced levels of Na, K-ATPase [39] .
of a and b subunits. While the a subunit contains the Overall, it appears that a reduction of Na, K-ATPase amino acids involved in catalytical function, ion transport expression occurs early in the development of heart failure, and cardiac glycoside binding, the function of the b probably before heart failure symptoms are present.
subunit is not completely understood although it is essenTo estimate the functional impact of a reduced protein tial for the normal activity of the enzyme [47] and is expression of Na, K-ATPase, it is important to know involved in the transport of the functional Na, K-ATPase whether less protein necessarily means less activity. This is to the plasma membrane. Several isoforms of the Na, of course the case in V measurements under experimen-K-ATPase have been identified for both a (a1, a2, a3 and max tal conditions in vitro [35, 40] , but it may not necessarily be a4) and b subunits (b1, b2 and b3) [48] which are the case in intact tissue, where factors like substrate expressed in a tissue specific manner. In human heart a1, availability and phosphorylation status influence Na, Ka2 and a3 are expressed together with b1 and at very low ATPase activity. In the absence of direct quantitative levels b2 in a region specific manner [35, 49] .
In the first report on Na, K-ATPase isoform expression duced (because a1 accounts for the vast majority of pumps in normal and failing human left ventricle, Allen et al. in the mouse heart). In contrast, the reduction of a1 found no significant alteration in the mRNA expressions of expression did not mimic cardiac glycoside treatment, but the isoforms [50] . However, also the total Na, K-ATPase was followed by hypocontractility. Thus, at least in mouse concentration was only non-significantly reduced by |10% heart, the isoforms of the Na, K-ATPase have different in that study. Later, Shamraj et al. [34] found that the impact on cardiac contractility which cannot be attributed mRNA expression pattern was different in samples from to different affinities for cardiac glycosides or different failing human hearts. On the protein level a1 (238%) and biochemical properties, but which may be the result of a3 (230%) were lower in failing human hearts than in distinct subcellular distribution. An important prerequisite non-failing hearts. In parallel, abundance of b1 (239%), for such conclusion, however, is the existence of subcellumaximal ouabain binding (239%) and Na, K-ATPase lar Na gradients and a fuzzy space for Na, which have not activity (242%) were lower, while the a2-isoform expresbeen clearly demonstrated to date. sion only showed a small tendency to a reduction [35] . In the right atrium from human failing hearts a1-and a2-isoforms, but not a3, were expressed at lower levels [51] .
4 . Myocardial Na, K-ATPase in digitalization For interpretation of the specific regulation and expression of Na, K-ATPase isoforms it is important to know Occupancy of Na, K-ATPase, i.e. percentage of reabout their specific functional properties. It is generally ceptors occupied by cardiac glycosides, during digitalizaaccepted that in the human heart the affinities of the tion was firstly evaluated by membrane potential measureisoforms for cardiac glycosides are almost identical. Howments in human atrial biopsies revealing a 38% reduction ever, two studies that investigated heterologously exin electrogenic effect [55] . Later occupancy in myocardial pressed human Na, K-ATPase isoforms found that ouabain biopsies from digoxin treated patients was determined as had a two-fold lower affinity for a2b1 than for a1b1 or the relative difference in digitalis glycoside binding before a3b1 [45, 46] . The affinity for Na was similar for all and after prolonged washing of the samples with buffer cardiac heteromers in one study [46] , while in the other containing digoxin antibody. This revealed occupancies of a1b1 had the highest and a3b1 the lowest affinity for Na 24-35% in the human heart [29, 56] . These numbers of [45] . There were no differences in the ATP-affinity receptor occupancy appear relatively high when the therabetween the isoforms, but the K-affinity was lower in peutic plasma concentrations of digoxin (|2.5 nM) or a2b1 than in a1b1 or a3b1. In consequence a2b1 ouabain (|1 nM) are compared with the affinities of requires higher extracellular K-concentrations (above 6 human isoforms for the drugs. In the absence of potassium, mM) to pump at maximal velocity. Interestingly, the the K -values of ouabain binding to human a1 and a3 D turnover rates of the different isoforms were also different, isoforms are 5-15 nM, and the K of ouabain for the a2 D with that for a1b1 being twice as high as that for a3b1. isoform is even higher (25-30 nM) [45, 46] . The presence Thus, two a3b1 heteromers are needed to match the of potassium in physiological concentrations further remaximal velocity of one a1b1 enzyme [45, 46] . These data duces this affinity with an approximate doubling of K -D indicate that downregulation of a1 may have a higher values [45] and, thus, reduces the fraction of Na, Kfunctional impact on overall cell Na, K-transport than ATPase enzymes occupied by cardiac glycosides at theradownregulation of a2 or a3.
peutic concentrations. The presumably low receptor ocBesides the specific biochemical properties, a specific cupancy in vivo may support the notion that other than subcellular distribution of the Na, K-ATPase isoforms may positive inotropic effects (e.g. central nervous effects) may influence their specific physiological and pathophysiologiplay an important role for the clinically beneficial effects cal role. Thus, in rat cardiomyocytes a1 isoform is of cardiac glycosides. On the other hand, the data observed concentrated in the transverse tubules and a2 is uniformly in the Na, K-ATPase knock-out mice seem to indicate that distributed throughout the sarcolemma [52] . In rat arterial the inhibition of the right isoform is more important than myocytes the a1 isoform was ubiquitously distributed over reducing overall Na, K-ATPase activity [54] . the surface of the cells, while a3 showed a reticular Some decades ago development of tolerance to chronic distribution similar to that of the Na / Ca-exchanger [53] . digoxin therapy was suspected based on the finding of Na, Such distribution may explain the findings that low dose K-ATPase upregulation in various tissues such as erythroouabain can increase intracellular Ca-concentration without cytes. However, when Na, K-ATPase was later studied in changes in bulk Na-concentration [10, 12, 13] . This hypoththe target organ for the inotropic action of digoxin, the esis is further supported by findings of James et al. [54] in human myocardium of patients with heart failure, no heterozygous knock-out mice in which cardiac expression evidence for development of tolerance to long-term diof either a1 or a2 was reduced by |50%. In this study, gitalization was found at the digoxin receptor level [29, 56] . only the reduction of a2 led to hypercontractility of the Recent studies using experimental animals indicate that heart, mimicking the effect of cardiac glycosides, although myocardial Na, K-ATPase is also influenced by other overall Na, K-ATPase activity was not significantly redrugs than digoxin used for treatment of heart failure.
Thus, potassium loss during diuretic therapy as well as role for blood pressure, heart rate and hemodynamics hyperaldosteronism induced by heart failure has been remains to be clarified. found to reduce the myocardial Na, K-ATPase, whereas angiotensin converting enzyme (ACE) inhibitors may stimulate Na, K-pump activity [57] [58] [59] .
. Clinical aspects and perspectives
One major aspect of reduced myocardial Na, K-pump 5 . Endogenous digitalis-like factor concentration in heart failure and an additional inhibition of a significant fraction of it during digitalization is its In 1982 a correlation was found between the coninfluence on Na and K homeostasis. Higher concentrations centration of a blood plasma component inhibiting Na, of intracellular Na have been observed in cardiomyocytes K-ATPase and blood pressure in humans [60] . A ouabainfrom heart failure patients and from failing rabbit hearts like factor was later found in the adrenal cortex, pituitary [41, 42] which may be induced by decrease in Na, K-pump and hypothalamus [61, 62] . In bovine adrenocortical cells a concentration [35] , but also increased Na-influx [41] . secretion of ouabain was found, suggesting an endogenous Higher concentrations of Na may stimulate Na, K-ATPase synthesis of this hormone [63] . However, the precise activity [45, 46] , while at resting conditions only a few per chemical structure and its pathway of synthesis remain cent of the Na, K-pumps have been found to be usually unknown [64, 65] . Some studies have found a rapid inactive [75] . On the other hand, only a reduced capacity for crease in plasma levels of endogenous ouabain suggesting Na handling is available when in demand. Thus, a Na rise i that it may play a role in acute circulatory regulation [66] , during e.g. ischemia may secondarily limit Ca and H others have found elevated plasma levels of endogenous extrusion from myocytes inducing arrythmias and lead to ouabain in patients with essential hypertension [67] . Howfurther progression of heart failure due to cell necrosis. ever, not all investigators were able to identify an endogenBesides intracellular Na, extracellular K homeostasis is ous ouabain compound in human plasma [68] . In spontalargely influenced by Na, K-ATPase activity. Here two neous hypertensive rats, no evidence of an endogenous important aspects should be considered, that is K handling digitalis-like factor was observed either when ouabain of the myocytes per se, and handling of K arriving at the binding to muscular tissue in vivo and in vitro was extracellular space of the heart via the blood stream. Both compared, or when samples were exposed to prolonged of these aspects of K homeostasis are affected by regulawashes before binding [69, 70] . The role of an endogenous tory aspects, e.g. regulation of the Na, K-pump by physioouabain in blood pressure regulation was supported by the logical and pathophysiological conditions as well as medifinding that prolonged infusion of ouabain induced suscal treatment [57, 76] . Thus, digitalization has been shown tained hypertension in rats [71] . On the other hand no to affect both parameters [17, 18] . Furthermore, in exhypertension was observed with digoxin or digitoxin [72] , perimental animals K-loading as well as K-depletion are which may explain the lack of pro-hypertensive effects of found to significantly affect K handling [77] [78] [79] . The e digitalization in humans. Although it has been suggested effects of K-depletion are of special interest since this may that ouabain is secreted from the adrenal gland, subsequent occur often in heart failure patients due to treatment with quantitative evaluations showed that the production rate diuretics [80] . Diuretics should clearly be used when fluid was so low that it would take |1 month to produce enough overload is present, but it may be more rational to reduce ouabain to obtain only a 1% occupancy of the Na, Kits use in chronic heart failure to the minimum and to add ATPase in the entire muscular pool [73] . When myocardial cardiac glycoside. samples from patients not treated with cardiac glycosides Finally, a major aspect of digitalization is the beneficial were exposed to prolonged washes with buffer containing influence on hemodynamics [81] . In failing human heart, digoxin antibody, no significant occupancy of the Na, an increased sensitivity to interventions that enhance 1 K-ATPase was revealed in binding experiments [29, 56] . In intracellular Na has been observed in vitro [34, 82, 83] and comparison, potassium-depletion has been found to be in vivo [84] . This is likely due to higher baseline cell associated with significant reductions in ouabain binding sodium secondary to depressed sodium pump activity. The site concentrations in resistance vessels of 33% [69] and functional and pharmacological role of Na, K-ATPase skeletal muscles of 78% [74] .
isoforms needs further elucidation in additional studies. In Thus, the results on the existence of endogenous ouathe only large study on the use of cardiac glycosides for bain and its putative significance are contradictory. It the treatment of heart failure, the Digitalis Investigation cannot be ruled out that some unspecific cross-reactions of Group (DIG) trial, beneficial effects of digoxin on morthe antibody used for the determination of the digitalis-like bidity and need for hospitalizations without affecting factor may play a role in some experiments. Moreover, the mortality were found [85] . Therefore, the available data quantity of this factor seems minute as compared to the support the recommendations of the guidelines of the enormous quantity of Na, K-ATPase in the human body, European Society of Cardiology [86] to use cardiac and if existing, its physiological and pathophysiological glycosides in the treatment of heart failure patients who
